Ulcerative colitis adult - change or recommencement authority application form (PB245)

Use this form to apply to change or recommence PBS-subsidised treatment with a biological medicine for adult patients with moderate to severe ulcerative colitis or etrasimod for patients with moderate to severe ulcerative colitis.

Biological medicine refers to:

  • adalimumab
  • etrasimod
  • golimumab
  • infliximab
  • ozanimod
  • tofacitinib
  • upadacitinib
  • ustekinumab
  • vedolizumab.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the ulcerative colitis adult - change or recommencement authority application form.

Page last updated: 1 May 2026.
QC 45981